Beware of False “Cures” for Autism
What you need to know
Unapproved and Potentially Harmful Products
Autism Spectrum Disorder (ASD) affects about 1 in 68 children, and while early behavioral therapies can help improve symptoms, there is no cure for autism. Unfortunately, some companies promote unproven products that falsely claim to treat or even cure ASD — and some can be dangerous.
What the FDA Wants You to Know
The FDA has acted against companies marketing unapproved and potentially harmful products that claim to treat autism. These include:
- Chelation Therapies (sprays, drops, baths): Meant to remove “toxins,” but can dangerously deplete essential minerals.
- Hyperbaric Oxygen Chambers: Only approved for specific medical uses — not autism.
- Detoxifying Clay Baths: Claim to “pull out toxins” through the skin — no evidence they help.
- MMS (chlorine dioxide), raw camel milk, essential oils, and others: Heavily marketed, not scientifically proven, and can pose real health risks.
FDA-Approved Treatments Exist — But Only for Specific Symptoms
There are two FDA-approved medications to manage irritability associated with autism:
- Risperidone (ages 5–16)
- Aripiprazole (ages 6–17)
These medications help with specific symptoms — not autism itself — and should only be used under medical supervision.
Real Help for ASD
- Early behavioral interventions can improve communication and daily living skills.
- Treatment should be tailored to the individual’s needs.
- Work with licensed healthcare professionals, not unregulated products.
Watch Out for These Red Flags
- “Quick fixes” or “miracle cures”
- Claims to treat a wide range of unrelated conditions
- Personal stories with no scientific backing
- Secret ingredients or “breakthrough science”
If it sounds too good to be true, it probably is.
If you have questions about therapies or treatments, talk to a doctor who specializes in autism. Trust science — not sales pitches.
FDA Breakthrough Devices Program
Program assists needed products with access to US market The U.S. Food and Drug Administration (FDA) has established the Breakthrough Devices Program, a voluntary program that aims to expedite the development, assessment, and review of medical devices that demonstrate...
FDA Explores Dental Device Safety Concerns
Dental Devices to Treat Sleep Apnea and TMD The FDA is currently evaluating safety concerns related to certain dental devices called fixed (non-removable) palatal expanders, which are used on adults for jaw remodeling or to treat conditions like obstructive sleep...
Update – Carcinoma Inside Capsule of Breast Implants
Squamous Cell Carcinoma and Various Lymphomas Located in the Capsule around Breast Implants On March 22, the US Food and Drug Administration (FDA) issued an update to its March 8 safety communication regarding reports of squamous cell carcinoma (SCC) and lymphomas in...